JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

F Zoulim, O Lenz, JJ Vandenbossche, W Talloen, T Verbinnen, I Moscalu, A Streinu-Cercel, S Bourgeois, M Buti, J Crespo, JM Pascasio, C Sarrazin, Thomas Vanwolleghem, U Shukla, J Fry, JZ Yogaratnam

Research output: Contribution to journalArticleAcademicpeer-review

86 Citations (Scopus)
Original languageEnglish
Pages (from-to)521-+
JournalGastroenterology
Volume159
Issue number2
DOIs
Publication statusPublished - 2020

Research programs

  • EMC MM-04-20-01

Cite this